{"schema_version":"secwatch.filing_event.v1","accession":"0001411690-23-000067","form_type":"8-K","ticker":"BNGO","cik":"0001411690","company_name":"Bionano Genomics, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.839011+00:00","generated_at":"2026-06-11T21:44:28.388610+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bionano Genomics Q2 revenue up 30% to $8.7M; flowcell sales more than double YoY","bullets":["Q2 2023 revenue $8.7M, +30% YoY; GAAP gross margin 27% vs 22%.","Installed Saphyr systems 281 (+43% YoY); flowcells sold 7,062 (+108% YoY).","GAAP operating expense $41.5M vs $33.6M; non-GAAP opEx $34.6M.","Cash & securities $77.1M at June 30, down from $95.8M at March 31.","Announced Stratys high-throughput OGM system and VIA software for hematologic malignancies."],"urls":{"canonical":"https://secwatch.observer/filing/0001411690-23-000067","json":"https://secwatch.observer/filing/0001411690-23-000067.json","markdown":"https://secwatch.observer/filing/0001411690-23-000067.md","text":"https://secwatch.observer/filing/0001411690-23-000067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/0001411690-23-000067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/bngo-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:44:28.388610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"def55c3eed0ed16436607bdb25ba31c25586cf63","claim":"Bionano Genomics, Inc. reported second quarter ended June 30, 2023 results: revenue $8.7 million.","evidence_excerpt":"filing to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress • Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022 • Installed base of Saphyr ® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022 • Sold 7,062","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411690/000141169023000067/0001411690-23-000067-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$8.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}